SearchDictionaryMobileLogin

Laparotomy

14503  relevant articles (319 outcomes, 756 trials/studies) found for this Therapy
Also Known As:
Minilaparotomy; Laparotomies; Minilaparotomies

Relationship Network

Therapy Context: Research Results

Experts

1. Tsuji, Takashi: 6 articles (10/2007 - 06/2002)
2. Yamaguchi, Hiroyuki: 6 articles (10/2007 - 06/2002)
3. Nakagoe, Tohru: 6 articles (10/2007 - 06/2002)
4. Sawai, Terumitsu: 6 articles (10/2007 - 06/2002)
5. Yasutake, Toru: 5 articles (01/2004 - 06/2002)
6. Nanashima, Atsushi: 5 articles (01/2004 - 06/2002)
7. Tsuji, T: 5 articles (11/2003 - 01/2001)
8. Nakagoe, T: 5 articles (11/2003 - 01/2001)
9. Sawai, T: 5 articles (11/2003 - 01/2001)
10. Whelan, R L: 5 articles (08/2002 - 05/2000)

Related Diseases

1. Neoplasms (Cancer)
2. Wounds and Injuries (Trauma)
12/01/1987 - "While most reported series classify lavage results as true-positive when intraperitoneal blood is found at exploration, even if secondary to trivial injuries which do not require surgical therapy (nontherapeutic laparotomy), we believe that these should be classified as false-positive results, as was done in this study. "
03/01/2002 - "The need for splenectomy was most significantly correlated with higher grades of splenic injury especially grades IV and V. The evolution in management of blunt splenic trauma has led to a significant improvement in splenic preservation and avoidance of laparotomy for many patients. "
02/01/1999 - "Safe and effective treatment of GI tract injuries is compatible with nonoperative management of most other injuries associated with blunt abdominal trauma in children, while reducing the risk of nontherapeutic laparotomy."
01/01/2006 - "We hypothesize that diagnostic laparoscopy provides important information for the treatment of children with abdominal trauma and is accompanied by improved diagnostic accuracy, reduction of nontherapeutic laparotomy rates, and a reduction of morbidity. "
08/01/1989 - "These results lead to the rejection of the null hypothesis and confirm the clinical observation that besides reducing operative trauma, discomfort, and cost, laparoscopic laser surgery is very effective in reducing intraperitoneal adhesions and causes significantly less postoperative adhesion formation than does laparotomy."
Order ALL the reference details at left...
3. Carcinoma (Carcinomatosis)
4. Ovarian Neoplasms (Ovarian Cancer)
5. Hodgkin Disease (Hodgkin's Disease)
01/01/1994 - "The aim of this review is to examine critically, in Hodgkin's disease and in non-Hodgkin's lymphomas, (a) whether combined modality treatment is superior to optimal radiotherapy or chemotherapy alone in most stages of the disease; (b) whether its indications could be further expanded by the use of new drug regimens and newer radiation techniques that can now substantially reduce the risk of long-term iatrogenic morbidity; and (c) whether it may become a necessary approach in the future because staging laparotomy and even lymphangiography are progressively falling into disuse. "
08/01/1984 - "No second primary lesions or death with complete remission were observed in Group II. Staging laparotomy with splenectomy in early-stage Hodgkin's disease did not improve the duration of remission or survival or decrease the number of abdominal relapses compared with closed staging."
09/01/1994 - "Laparotomy staged patients who received radiotherapy only for stage I and II Hodgkin's disease had better outcome than clinically staged patients. "
04/01/1985 - "The immune deficiencies of Hodgkin's disease persist to some degree even after the patients are clinically cured; these may be amplified by loss of splenic immunologic functions after staging laparotomy and splenectomy. "
08/01/1976 - "Staging laparotomy, consisting of splenectomy and biopsies of liver, lymph nodes, and bone marrow, is a very useful adjunct in the workup of a patient with Hodgkin's disease. "
Order ALL the reference details at left...

Related Drugs and Biologics

1. Cisplatin (Platino)
2. Platinum
3. Anti-Bacterial Agents (Antibiotics)
4. Cosmetics
5. Bupivacaine (Bupivacaine Hydrochloride)
6. Doxorubicin (Adriamycin)
7. Methotrexate (Mexate)
8. Biological Tumor Markers (Tumor Markers)
9. monophosphoryl lipid A
10. (3,4-dihydroxyphenylamino)-2-imidazoline (DPI)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Splenectomy
3. Combination Drug Therapy (Combination Chemotherapy)
4. Cholecystectomy
5. Hysterectomy

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 20112 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>